Company Search:
Advanced Search
Sponsored Links
Flamel Technologies S.A. - ADR Company Snapshot
Flamel Technologies S.A. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Flamel Technologies S.A. with three other companies in this sector in the United States: FibroGen Inc (2015 sales of $180.83 million ), MusclePharm Corp ($166.86 million of which 100% was Sport Beverages), and Pernix Therapeutics Holdings Incorporated ($175.85 million of which 100% was Pharmaceutical Product).

Sales Analysis. Sales increased substantially in 2015: Flamel Technologies S.A. reported sales of $173.21 million for the year ending December of 2015. This represents an increase of 1,072.3% versus 2014, when the company's sales were $14.77 million.
  Stock Performance Chart for Flamel Technologies S.A. - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 10.99
(Figures in U.S. Dollars)
1 Week 0.8%   13 Weeks 15.4%  
4 Weeks -22.2%   52 Weeks -26.3%  
Flamel Technologies S.A. - ADR Key Data:
  Ticker: FLML Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 173,209,112
(Year Ending Jan 2016).
Employees: 109
  Currency: U.S. Dollars Market Cap: 453,238,590
  Fiscal Yr Ends: December Shares Outstanding: 41,241,000
  Share Type: Ordinary Closely Held Shares: 6,305,726
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.